An Act relative to newborn screenings for congenital cytomegalovirus

This bill mandates that Massachusetts begin offering universal newborn screenings for congenital cytomegalovirus (CMV) starting July 1, 2027. The legislation requires hospitals and birthing facilities to test all newborns using saliva or urine PCR tests, with results shared with parents, doctors, and the state within 21 days of birth. Healthcare providers must also provide expectant parents with evidence-based information about CMV prevention and support resources during prenatal and postnatal care visits. While the bill includes a religious exemption allowing parents to opt out of the screening, it also establishes a new advisory committee to oversee the program's implementation and ensure accurate testing standards.